Category:
Preclinical Research Services
CAS NO:
32046-26-7
Standard:
ChP,
Acipimox (CAS: 2507-84-0; Formula: C6H7NO2) is a niacin derivative synthesized via condensation of nicotinic acid with acetone. It functions as an antilipemic agent primarily used to lower plasma triglycerides and free fatty acids.
Contraindicated in severe hepatic impairment or active peptic ulcers. Store below 25°C in dry, light-resistant conditions. Monitor liver enzymes periodically during long-term industrial formulation use.